This suggests that ACTL6A/ACTR6 may be independent risk factors for predicting the prognosis of HCC patients, with ACTR6 showing the lowest p-value of 0.001 in multivariate Cox analysis (Figure 2D). This evidence concerns the gene ACTR6 and hepatocellular carcinoma.